Accordingly, a new strategy for prevention and treatment of depression has emerged targeting inflammation (the pro-inflammatory cytokines and the pathways involved in their upregulation and overactivation) to ameliorate signs of depression through reducing IDO-1. This evidence concerns the gene IDO1 and major depressive disorder.